Ovid Therapeutics is a brand that is boldly transforming the lives of individuals affected by rare neurological diseases, including Angelman syndrome, Fragile X syndrome, and rare epilepsies. They are focused on developing impactful medicines that can make a difference in the lives of patients with these conditions. With a vision and leadership centered around science and pipeline development, Ovid Therapeutics is dedicated to translating discoveries of human genetics and cellular function into meaningful therapies for epilepsies and seizure-related disorders.

Their commitment lies in understanding the challenges faced by individuals with rare diseases and their families, and addressing them head-on. Notably, Ovid Therapeutics boasts a team of passionate individuals who share a deep understanding of the transformative power of medicine. They strive to go beyond just developing drugs and instead aim to change lives and create a positive impact in the world.

For those seeking top-notch treatment options for rare neurological disorders, Ovid Therapeutics offers a beacon of hope and a commitment to a better future